Limitations of Intrathecal Baclofen for Spastic Hemiparesis Following Stroke

Objective. Intrathecal baclofen (ITB) has become the first choice in the management of deleterious spasticity that does not respond to oral and intramuscular medications following spinal cord injury, traumatic brain injury, and cerebral palsy. The usefulness of ITB in severe spastic hemiparesis foll...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Neurorehabilitation and neural repair 2009-01, Vol.23 (1), p.26-31
Hauptverfasser:	Kofler, Markus, Quirbach, Ellen, Schauer, Robert, Singer, Markus, Saltuari, Leopold
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Baclofen - administration & dosage Baclofen - adverse effects Child Dose-Response Relationship, Drug Female GABA Agonists - administration & dosage GABA Agonists - adverse effects Gait Disorders, Neurologic - chemically induced Gait Disorders, Neurologic - physiopathology Humans Injections, Spinal Male Middle Aged Motor Neurons - drug effects Muscle Spasticity - drug therapy Muscle Spasticity - etiology Muscle Spasticity - physiopathology Muscle Tonus - drug effects Muscle Tonus - physiology Muscle Weakness - chemically induced Muscle Weakness - physiopathology Muscle, Skeletal - innervation Muscle, Skeletal - physiopathology Pain - drug therapy Pain - etiology Pain - physiopathology Paresis - drug therapy Paresis - etiology Paresis - physiopathology Spinal Cord - drug effects Spinal Cord - physiopathology Stroke - complications Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!